The role of platelets in the pathogenesis of vasculitis and the formation of coronary artery aneurysms was studied in 19 children with Kawasaki disease and five with polyarteritis. All patients with Kawasaki disease developed thrombocytosis in the third week of illness. The peak platelet count was significantly correlated (p <0 005) with the subsequent development of coronary artery aneurysms. The rise in platelet count was associated with the appearance in the circulation of a factor that induced aggregation and serotonin release in normal platelets. This factor was shown to be of high molecular weight, and its activity was lost at low pHfeatures suggestive of an immune complex. Immune complexes, detected by precipitation with polyethylene glycol, also appeared in the circulation as the platelet count increased. These complexes induced platelet aggregation, and there was a significant correlation (p <0 001) between the concentrations of IgG and IgA in the polyethylene glycol precipitated material and the platelet aggregating activity. Similar platelet aggregating activity was also detected in patients with polyarteritis but followed a different time course, persisting in the circulation for several months in association with continued disease activity. These findings imply that different mechanisms have a role in distinct phases of Kawasaki disease. The initial feverish phase (probably infective) is probably followed by an immune complex vasculitis that occurs when antibodies to the initiating agent appear in the circulation. The immune complexes aggregate platelets and induce release of serotonin. Platelet derived vasoactive mediators may increase vascular permeability and facilitate further deposition of complexes in the tissues.
Introduction
Kawasaki disease, or the mucocutaneous lymph node syndrome, is an acute, feverish illness affecting young children, with prominent mucocutaneous and cardiovascular manifestations.' Since its description in 1967 many thousands of cases have been seen in Japan, and the disease is recognised increasingly often in many other countries. 23 Kawasaki disease is often a benign and self limited illness. Arteritis affecting the extraparenchymal muscular arteries is, however, common and results in the development of coronary artery aneurysms in 20-600o of cases.46 Death due to coronary artery thrombosis, myocardial infarction, or aneurysm rupture occurs in 1-2 80,, of patients in the first three months of the illness,2 4-6 and there are reports of sudden death due to myocardial infarction occurring months to years after the initial illness.
Coronary artery aneurysms and myocardial infarction are most commonly detected after the second week of the illness and usually occur at a time when the fever and mucocutaneous manifestations are subsiding and the child appears to be convalescing.8 Thrombocytosis also occurs at this time, with the platelet count often exceeding 1000 x 109/1.2 This puzzling temporal association of thrombocytosis with the development of coronary artery aneurysms and thrombosis led us to investigate the role of platelets in the pathogenesis of Kawasaki disease and also in the related disorder, childhood polyarteritis.
Patients and methods
Nineteen children fulfilling the criteria for Kawasaki In eight patients platelet aggregating activity was also determined in plasma using a Payton dual channel aggregometer coupled to a Rikadenki recorder. Test plasma 200 jul was added to 200 ,1 washed normal platelets (final platelet count 150-300 x 109/1) in an aggregometer cuvette. The mixture was stirred at 900 rpm for five minutes and the aggregation recorded. We determined the effect on aggregation of prostacyclin 10 ng/l, albumin 2 g/l, 5 mM edetic acid, and 2 5 mM calcium solution. Plasma from a control was tested simultaneously in each experiment.
RELEASE OF SEROTONIN
The effect of patients' or controls' plasma on serotonin release from normal platelets was assessed as follows: platelets from a control were washed with metrizamide and labelled at room temperature with serotonin, labelled with carbon-14, (5- 
DETECTION OF PLATELET AGGREGATING ACTIVITY
The rise in platelet count was closely associated with a rise in serum platelet aggregating activity (as detected by platelet aggregating titre) in patients with Kawasaki disease (fig 2) and in four of the five with polyarteritis. The peak level of platelet aggregating material coincided with a peak in the platelet count, and platelet count and platelet aggregating titre were significantly correlated (p < 0001; Spearman rank test). In contrast with the transient rise in platelet aggregating material seen in Kawasaki disease, the increase in platelet aggregating titre persisted in the patients with polyarteritis, often for many months in association with continued disease activity.
Plasma from each of the eight patients tested (four with polyarteritis and four with Kawasaki disease) aggregated washed normal platelets on stirring in the aggregometer. Figure 4 shows a typical example. (table II) , whereas release did not occur using normal plasma.
ISOLATION OF PLATELET AGGREGATING MATERIAL
The fractions of serum and plasma from patients with Kawasaki disease or polyarteritis prepared by sucrose density gradient ultracentrifugation were tested for platelet aggregating activity by both the platelet aggregating titre test (serum) and aggregometry (plasma). Aggregating activity was detected in the high molecular weight fractions ( 19 S) prepared at neutral pH. Fractions prepared under dissociating conditions for immune complexes at pH 3 contained no aggregating activity (fig 5) . The precipitate of serum from patients with Kawasaki disease or polyarteritis obtained after incubation with 20°polyethylene glycol induced platelet aggregation when tested by the platelet aggregating titre test in the presence of calcium (n = 5). IgG immune complexes were raised in 13 (68°O) of 19 tests in patients with Kawasaki disease. There was a highly significant correlation (p < 0 001; Spearman rank correlation) between the rise in platelet aggregating titre and the rise in IgG complexes (fig 6) . IgA complexes were detected in 850, of patients with Kawasaki disease, and there was a significant correlation between the presence of IgA complexes and the rise in platelet aggregating titre (p < 0-001). A similar correlation was not observed for IgM (raised in 10 patients (550°)) or IgE complexes.
All patients with polyarteritis had appreciably raised concentrations of IgG, IgA, and IgM complexes. The concentrations of IgG and IgM complexes were significantly higher irn the patients with polyarteritis than in those with Kawasaki disease.
Discussion
The pathogenesis of Kawasaki disease remains unknown despite its worldwide occurrence and the intensive investigation of many thousands of cases. The clinical features of the illness, with fever, leucocytosis, and raised acute phase reactants, suggest an infective process, a possibility that is supported by the occurrence of epidemics,'2 geographical and temporal clustering,'3 seasonal variation,'2 ' and occasional simultaneous occurrence in siblings.'4 Despite recent reports, however, implicating a variant strain of the aerobic organisms Propionibacterium acnes transmitted by a mitel5 and earlier studies suggesting infection with rickettsia like organisms'6 17 attempts to isolate the causative agent have been unsuccessful. Furthermore, the failure to respond to antibiotics (including those active against rickettsia and anaerobes), the lack of case to case transmission,'2 13 and the progression of the disease despite negative cultures suggest that factors other than infection play a part.
An alternative hypothesis is that the disease is due to an immunological reaction to either a ubiquitous micro-organism or some other environmental agent. This is supported by the systemic vasculitis, a reported association with atopy, raised IgE concentrations,'8 and the presence of immune complexes,'8 -20 which have been detected in some but not all studies. ' A role has been suggested for platelets in the pathogenesis of the lesions in the coronary arteries and other vessels: platelets are hyperaggregable in both acute and convalescent phases of the disease,22 23 aggregating activity, and there is a highly significant correlation between the amount of IgG and IgA that can be precipitated with polyethylene glycol and the platelet aggregating activity. Similar platelet aggregating material is also detected in patients with polyarteritis but follows a different time course, persisting in the circulation for months or years in association with continued disease activity. These findings suggest that Kawasaki disease has three distinct pathophysiological phases. During the first fever, lymphadenopathy, and mucocutaneous manifestations occur, the platelet count is normal, and neither platelet aggregating activity nor immune complexes are detectable in the circulation. In the second, in the third to fifth weeks, when the fever and systemic symptoms are subsiding and desquamation has started, a dramatic rise in the platelet count occurs and platelet aggregating material and immune complexes become detectable. (It is during this phase that aneurysms are most often detected and death from coronary artery thrombosis is most likely to occur., 8) The association of thrombocytosis with the presence of circulating platelet aggregating material is paradoxical. Aggregated or damaged platelets are normally rapidly removed from the circulation by the reticuloendothelial system, and thus thrombocytopenia rather than thrombocytosis might have been the expected consequence. In animal models saturation of the reticuloendothelial system appreciably delays the clearance of injected colloidal carbon aggregates.29 Similar observations have been made in patients with immune complex diseases in whom delayed reticuloendothelial system clearance of heat damaged or IgG coated red cells has been shown.'0 " Small immune complexes may saturate the reticuloendothelial system and prevent the clearance of larger immune complexes32 or platelet aggregates. Thrombocytosis may therefore be an indication of saturation of the reticuloendothelial system by immune complexes, a possibility substantiated by the positive correlation between platelet count and immune complex titres. An additional possibility is that thrombopoiesis may be stimulated by a product released from aggregated platelets, such as platelet derived growth factor.
The question of whether Kawasaki disease, infantile polyarteritis, and adult polyarteritis represent different diseases or overlapping end results of the same process has caused considerable debate." Our findings suggest that interactions between immune complexes and platelets are important in both disorders. In contrast, however, with the transient rise and fall of platelet aggregating complexes in Kawasaki disease, in polyarteritis the platelet aggregating immune complexes persist in the circulation for months or years, in association with active disease. Whether this persistence is due to a defect in immune elimination of antigen or to a continuing antigenic exposure is not known. A key question requiring further study is whether Kawasaki disease is due to a single (infective) antigen or an immune response to various antigens and whether these antigens are distinct from those in polyarteritis.
Finally, the pathogenic mechanisms we have described have several clinical and therapeutic implications. Patients with the highest platelet counts also have the highest titres to immune complexes and are most likely to develop coronary artery aneurysms. The peak platelet count may therefore be a marker of severe disease and could be used to identify a group of patients requiring more aggressive treatment. Antiplatelet agents may be beneficial in reducing not only the risk of thrombosis but also the severity of the vasculitis.
